Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 100
- Avg volume
- —
- Day's range
- $436.55 – $436.55
- Shares out
- —
- Stochastic %K
- 56%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoir...
Show more
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, pharmacies and patients via subsidiaries and distributors. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
- Industry
- Medical Instruments & Supplies
- Sector
- Healthcare
- Phone
- 41 34 424 41 11
- Website
- https://www.ypsomed.com
- Address
- Brunnmattstrasse 6, Burgdorf, Switzerland
Latest news
No headlines yet.
